GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)

Market Cap	2.34T
Revenue (ttm)	60.33B
Net Income (ttm)	-61.59B
Shares Out	41.97M
EPS (ttm)	-1,551.71
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	94,416
Average Volume	169,250
Open	54,800
Previous Close	55,200
Day's Range	54,400 - 57,700
52-Week Range	9,060 - 72,700
Beta	1.03
RSI	46.74
Earnings Date	Aug 14, 2025

About The Aaron's Company

GemVax&KAEL Co.,Ltd engages in the manufacturing and selling of coating resins and filters for semiconductors and display production in South Korea. The company offers CA filter and gas scrubber resins for pollution control in the semiconductor and display sectors. It also engages in the research and development of anti-cancer vaccines. The company was founded in 1998 and is headquartered in Daejeon, South Korea.

• Industry: Special Industry Machinery, not elsewhere classified
• Founded: 1998
• Employees: 192
• Stock Exchange: KOSDAQ
• Ticker Symbol: 082270

Financial Performance

In 2024, GemVax&KAEL's revenue was 62.69 billion, a decrease of -13.18% compared to the previous year's 72.21 billion. Losses were -87.22 billion, 220.9% more than in 2023.

Financial numbers in CAD